Sage Therapeutics (SAGE) Competitor Comparison
We are evaluating the key criteria listed to compare Sage Therapeutics (SAGE) against its competitors in the Biotechnology industry.
Market Capitalization
107 / 368Gross Profits
272 / 278Total Revenue
181 / 300EBITDA
330 / 337Free Cashflow
338 / 352Quick Ratio
139 / 357Earnings per Share
311 / 359Dividend yield
0 / 6Total Cash
28 / 358Performance 3 years
271 / 368Performance 5 years
324 / 368Performance 10 years
223 / 368Linearity 3 years
136 / 368Linearity 5 years
270 / 368Linearity 10 years
53 / 368Total Rank
353 / 368Dividend Rank
265 / 368Valuation Rank
227 / 368Piotroski Rank
311 / 368Muliplier Rank
199 / 368Earnings per Share - SAGE ranking 311 / 359
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.